Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-04

Clinical Trial Update: Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports on the immunogenicity and safety of both inactivated and live-attenuated hepatitis A vaccines in healthy Thai childre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated hepatitis A vaccine (Hepatitis A vaccine, inactivated)
  • Live-attenuated hepatitis A vaccine (Hepatitis A vaccine, live-attenuated)

Snippet

Sponsor: Chiang Mai University | Conditions: HAV, Hepatitis A | Phase 3 | Status: COMPLETED